Jump to page content Accessibility
News, views and contacts from the global Drugdevelopment industry
Login to drugdevelopment-technology.com Log in or Register
  • Home
  • Products & Services
  • Company A - Z
  • Projects
  • Features
  • Videos
  • White Papers
  • News
  • Events
  • Advertise With Us
Industry Projects | Projects by Region | Projects by Category | Archived Projects | Project Gallery
 

Bifeprunox - Atypical Antipsychotic Drug



At Weesp in the Netherlands, Solvay Pharmaceuticals carries out research into medicines for psychiatric and neurological disorders such as schizophrenia.


  • Bifeprunox mesilate is a novel atypical antipsychotic agent under development...

  • Atypical antipsychotic drugs routinely used in the treatment of schizophrenia.

  • Cross section of the human brain showing dopamine and serotonin pathways....

  • D2 receptor binding of typical and atypical antipsychotic drugs. (Source: ABPI)

  • Solvay Research & Technology in Neder-over-Hembeek, Belgium, is the company's...

  • At Weesp in the Netherlands, Solvay Pharmaceuticals carries out research into...

  • Core symptoms of schizophrenia.

  • The automated molecular assembly plant (AMAP) boosts the efficiency of Solvay...

Back to Project Details



Related Projects

Ariflo (Cilomilast) - Oral PDE-IV Inhibitor for
Ariflo (cilomilast) is an oral selective phosphodiesterase (PDE) IV...

Fablyn (Lasofoxifene) - Investigational SERM
The product of a joint development programme between Pfizer and...

Rupintrivir -
Agouron Pharmaceuticals, a subsidiary of Pfizer, has pioneered...

Xolair - Biological Therapy
The product of a joint development programme between Tanox, Genentech...

Tarceva - Small Molecule
Tarceva (erlotinib) is an oral anti-cancer drug developed by...

See all projects


Contact us
Advertise with us
Terms and conditions
Privacy
Links
Newsletter sign up
Online magazine sign up

drugdevelopment-technology.com is a product of Net Resources International. Copyright 2011 Net Resources International, a trading division of SPG Media Limited.